1. Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
   Roukiah Khalil et al, 2023, Cancers CrossRef
2. Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer
   Petros Christopoulos et al, 2024, JCO Precision Oncology CrossRef
3. B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas
   Susan Raju Paul et al, 2023, FASEB BioAdvances CrossRef
4. BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
   Clemence Demerlé et al, 2021, Frontiers in Oncology CrossRef
5. Immunological markers for predicting the response to immunotherapy in non-small cell lung cancer
   A. A. Musaelyan et al, 2022, Advances in Molecular Oncology CrossRef